View All Conferences
In Anaheim, California brings together doctors in primary care, family medicine, pediatrics, and internal medicine, offering dozens of new CME courses to improve patient care across 19 specialty areas.
A Roadmap to Lower a1c Control May Have CV Benefits
"It's not rocket science," says Ashok Balasubramanyam, MD.
The Best Atrial Fibrillation Treatment Practices
AF is linked with increased risks of stroke, dementia, and heart failure.
Emerging Infections: The Wrath of Zika
A physician shares the history of Zika, best practices to limit transmission.
To Err is Human, but Doctors Should Try to Avoid That
Panagiota Caralis, MD, lectures on strategies for avoiding medical errors.
Anju Peters, MD, Updates Doctors on the Knowns and Unknowns of Food Allergy
Peters gave a primer on peanuts and more at Pri-Med West.
STD Update: Chlamydia Stays Simple as Gonorrhea Adapts
Richard Johnson, MD, kept the mood light while giving the latest in STD care.
While Understanding of Alzheimer's is Evolving, Countless Unanswered Questions Remain
Alzheimer's authority Gary Small, MD, gave detailed update of current treatment.
Countering the Alarming Trend in Cardiovascular Deaths
After decades of decline, heart disease mortality is on the rise again.
Contrasting Views on Blood Pressure Recommendations for Patients Over 60
What are existing strategies to prevent heart disease?
Updates from American College of Cardiology Pertinent to Primary Care Physicians
What topics are important for PCPs to understand to treat their CVD patients?
Seeing into the Future Collaborative Care to Maintain Eye Health in Patients with Diabetes
Primary care physicians (PCPs) and ophthalmologists (including retina specialists) can effectively collaborate to minimize the occurrence of blindness in their diabetic patients.
New Therapies for Heart Failure Could Save Thousands of Lives
PCPs must be aware of all potential therapies to help reduce the burden of HF.
Managing T2DM to Control CVD in Diabetic Patients
How a combination of the conditions can take 15 years off a patient's life expectancy.
Janssen Ends Canagliflozin CREDENCE Trial Early After Hitting T2D, CKD Endpoints
Improving Therapeutic Options for Patients With PTSD
FDA Approves First Complete, Darunavir-Based Single Tablet for HIV
Misconceptions Exist About Clinical Evidence for Breakthrough Therapies, Examination Suggests
Syringe Services Program Implemented During HIV Outbreak Led to Reduction of Injection-Related Risk Behaviors
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.